Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.

Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.

Bibliographic Details
Main Authors:	Demaria, S, Dustin, M
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment.
by: Demaria, S, et al.
Published: (2013)

Dual Checkpoint Aptamer Immunotherapy: Unveiling Tailored Cancer Treatment Targeting CTLA-4 and NKG2A
by: Mohamad Ammar Ayass, et al.
Published: (2024-03-01)

Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.
by: Ruocco, MG, et al.
Published: (2012)

CTLA4 polymorphisms and COPD.
by: Wood, A, et al.
Published: (2010)

Micro-abnormalities in the retina and choroid induced by anti-CTLA4 treatment
by: Ryo Mukai, et al.
Published: (2023-04-01)

64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues.
by: Kei Higashikawa, et al.
Published: (2014-01-01)

CTLA4 gene polymorphism and autoimmunity.
by: Gough, S, et al.
Published: (2005)

Role of CTLA4 immunohistochemistry in the diagnosis of colon cancers
by: Vishnu Narayanan, et al.
Published: (2022-01-01)

Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
by: Yinghao Zhao, et al.
Published: (2018-05-01)

Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
by: Erika Salvatori, et al.
Published: (2022-02-01)

Mechanistic Elucidation and Therapeutic Improvement of Anti-CTLA-4 Therapies
by: Lax, Brianna Marie
Published: (2023)

Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
by: Chan-Young Ock, et al.
Published: (2017-10-01)

CTLA-4 in Regulatory T Cells for Cancer Immunotherapy
by: Navid Sobhani, et al.
Published: (2021-03-01)

Effects of CTLA4-Ig on human monocytes
by: Toshihiro Tono, et al.
Published: (2017-11-01)

Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.
by: Amit K Mittal, et al.
Published: (2013-01-01)

Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells.
by: Bachmann, M, et al.
Published: (1998)

Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
by: Mehregan Babamohamadi, et al.
Published: (2024-01-01)

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
by: Amirali Karimi, et al.
Published: (2021-03-01)

CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma
by: Friederike Hoffmann, et al.
Published: (2023-07-01)

CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability
by: Diana Russo, et al.
Published: (2021-03-01)

Combination of CTLA-4 and PD-1 blockers for treatment of cancer
by: Anand Rotte
Published: (2019-06-01)

The expression of CTLA-4 in hepatic alveolar echinococcosis patients and blocking CTLA-4 to reverse T cell exhaustion in Echinococcus multilocularis-infected mice
by: Yuxuan Yang, et al.
Published: (2024-03-01)

CTLA-4 CT-60 A/G and CTLA-4 1822 C/T Gene Polymorphisms in Indonesians with Type 1 Diabetes Mellitus
by: Rochmah N, et al.
Published: (2022-04-01)

624 Longitudinal scRNAseq profiling of PBMCs from melanoma patients treated with anti-CTLA4 or anti-PD1/CTLA4 combination elucidates mechanisms of immunotherapy resistance
by: Rupal Bhatt, et al.
Published: (2023-11-01)

CTLA-4 Expression Plays a Role in PSC and PBC Progression
by: Phil Meister, et al.
Published: (2020-06-01)

The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology
by: Shashuang Zhang, et al.
Published: (2020-03-01)

Identification of CTLA-4-Positive Cells in the Human Tonsil
by: Markus Tiemann, et al.
Published: (2021-04-01)

Polymorphism analysis of the CTLA-4 gene in paracoccidioidomycosis patients
by: Viviane F Lozano, et al.
Published: (2011-03-01)

Comparison of the intracellular trafficking itinerary of ctla-4 orthologues.
by: Satdip Kaur, et al.
Published: (2013-01-01)

CTLA-4 correlates with immune and clinical characteristics of glioma
by: Fangkun Liu, et al.
Published: (2020-01-01)

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
by: Judith A. Seidel, et al.
Published: (2018-03-01)

Elaborating on anti CTLA-4 mechanisms of action using an agent-based modeling approach
by: Ivan Azarov, et al.
Published: (2022-10-01)

Re-engineering anti-CTLA-4 antibodies for enhancing cancer immunotherapy efficacy and safety
by: Sharvesh Raj Seeruttun
Published: (2019-09-01)

Synergistic effect of CTLA-4 blockade and cancer chemotherapy in the induction of anti-tumor immunity.
by: W Joost Lesterhuis, et al.
Published: (2013-01-01)

The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection
by: Ása Didriksen Apol, et al.
Published: (2023-05-01)

Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
by: Sara Valpione, et al.
Published: (2018-04-01)

Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice.
by: Manli Na, et al.
Published: (2017-01-01)

A common CTLA4 haplotype associated with coeliac disease
by: Hunt, K, et al.
Published: (2005)

A common CTLA4 haplotype associated with coeliac disease.
by: Hunt, K, et al.
Published: (2005)

Peptide Blocking CTLA-4 and B7-1 Interaction
by: Stepan V. Podlesnykh, et al.
Published: (2021-01-01)